First Time Loading...

PharmaSGP Holding SE
XETRA:PSG

Watchlist Manager
PharmaSGP Holding SE Logo
PharmaSGP Holding SE
XETRA:PSG
Watchlist
Price: 22.6 EUR -1.74%
Updated: May 6, 2024

PharmaSGP Holding SE
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaSGP Holding SE
Revenue Peer Comparison

Comparables:
ATAI
BAYN
MRK
93M1
DMP

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
PharmaSGP Holding SE
XETRA:PSG
Revenue
€85.8m
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Revenue
$314k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Revenue
€47.6B
CAGR 3-Years
5%
CAGR 5-Years
5%
CAGR 10-Years
2%
Merck KGaA
XETRA:MRK
Revenue
€21B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
7%
MPH Health Care AG
XETRA:93M1
Revenue
€37.4k
CAGR 3-Years
-5%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Revenue
€1.1B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
N/A

See Also

What is PharmaSGP Holding SE's Revenue?
Revenue
85.8m EUR

Based on the financial report for Dec 31, 2022, PharmaSGP Holding SE's Revenue amounts to 85.8m EUR.

What is PharmaSGP Holding SE's Revenue growth rate?
Revenue CAGR 5Y
10%

Over the last year, the Revenue growth was 31%. The average annual Revenue growth rates for PharmaSGP Holding SE have been 11% over the past three years , 10% over the past five years .